| ||||||||||||
| Morningstar.com Earlier this year, Vanguard closed Vanguard Primecap Core (NASDAQ:VPCCX - News) to new investors, shutting what had been the only avenue left to invest with the redoubtable subadvisors from Primecap Management Company directly through Vanguard. So, where's a contrarian growth investor to go now? What other open actively managed funds at Vanguard or elsewhere follow a similar strategy of trying to buy and hold fundamentally solid growth companies when they are out of favor or attractively priced?
You're No Primecap There's Vanguard US Growth (NASDAQ:VWUSX - News), whose subadvisors, AllianceBernstein and William Blair, both purport to invest in very large firms with competitive advantages and unappreciated growth opportunities. It has staged a comeback recently, but I'd still like to see a longer track record of success at this fund, which has seen its share of ups and downs and manager changes over the past decade, before giving it an unqualified endorsement. Perhaps the most proven remaining actively managed Vanguard growth fund is Vanguard Morgan Growth (NASDAQ:VMRGX - News). The fund has multiple subadvisors, but Wellington Management's Paul Marrkand pulls the most weight. The portfolio has lots of exposure to stocks with wide moats, or competitive advantages, and owns more mid- and small-cap stocks than the typical large growth fund. It's a combination of solid, but not necessarily outstanding, managers that should do well over time--but it's no Primecap. Straight to the Source Odyssey Aggressive Growth is a small- and mid-cap leaning fund that is most like Vanguard Capital Opportunity (NASDAQ:VHCOX - News) before asset growth caused it to migrate toward large-cap stocks; and Odyssey Growth resembles the current Capital Opportunity. You have to go directly to Primecap or to another brokerage, such as Charles Schwab, to buy the Odyssey funds, which are a bit more expensive than their Vanguard counterparts but still are good deals. Outsourcing Milano isn't afraid to look in non-traditional areas for unappreciated growth stocks and usually puts together portfolios that are anything but benchmark clones, which is one of the keys to beating the indexes. Growth Fund of America has enduring advantages that help it overcome its gargantuan asset base, particularly a deep and seasoned pool of managers, a valuation-conscious approach, and a low expense ratio. The analysts that support redoubtable managers Chris Davis and Ken Feinberg on large-cap blend standouts Selected American Shares (NASDAQ:SLADX - News) and Davis New York Venture (NASDAQ:NYVTX - News) run Selected Special and Davis Opportunity. With Davis' oversight, the analysts are allowed to range over market cap, sector, region, and style boundaries for ideas. The result is an eclectic portfolio that is more willing to own growth stocks than its advisors' larger funds. The funds also got a substantial fee cut this past summer. Dan Culloton has a position in the following securities mentioned above: POAGX Morningstar Premium Members get access to over 3,900 Stock and Fund Analyst Reports, Analyst Picks, and award-winning portfolio tools. Learn More.
| ||||||||||||